GTAB B — Glycorex Transplantation AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK67.35m
- SEK64.99m
- SEK29.96m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.53 | ||
| Price to Tang. Book | 3.14 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -59% | ||
| Return on Equity | -51.29% | ||
| Operating Margin | -101.04% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 36.1 | 27 | 28.2 | 36.12 | 29.96 | n/a | n/a | -2.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +130.66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Glycorex Transplantation publ AB is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. As of December 31, 2011, Glycosorb-ABO was used in 103 transplantation centers in 22 countries. As of December 31, 2011, the Company had four wholly owned subsidiaries, namely Glycoprobe AB, Glycorex Transplantation, Glycorex UMC AB and Glycorex UBP AB.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 13th, 1995
- Public Since
- July 6th, 1998
- No. of Employees
- 23
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Nordic Growth Market - Stockholm
- Shares in Issue
- 73,853,983
- Address
- Scheelevagen 27, LUND, 223 63
- Web
- https://glycorex.com/
- Phone
- +46 462865230
- Auditors
- Ernst & Young
Upcoming Events for GTAB B
FAQ
What is the Glycorex Transplantation AB (publ) share price?
As of Today at 19:09 UTC, shares in Glycorex Transplantation AB (publ) are trading at SEK0.91. This share price information is delayed by 15 minutes.
How has the Glycorex Transplantation AB (publ) share price performed this year?
Shares in Glycorex Transplantation AB (publ) last closed at SEK0.91 and the price had moved by -76.13% over the past 365 days. In terms of relative price strength the Glycorex Transplantation AB (publ) share price has underperformed the FTSE Global All Cap Index by -78.13% over the past year.
What are the analyst and broker recommendations for Glycorex Transplantation AB (publ)?
There is no consensus recommendation for this security.
What is the Glycorex Transplantation AB (publ) dividend yield?
Glycorex Transplantation AB (publ) does not currently pay a dividend.
Does Glycorex Transplantation AB (publ) pay a dividend?
Glycorex Transplantation AB (publ) does not currently pay a dividend.
When does Glycorex Transplantation AB (publ) next pay dividends?
Glycorex Transplantation AB (publ) does not currently pay a dividend.
How do I buy Glycorex Transplantation AB (publ) shares?
To buy shares in Glycorex Transplantation AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Glycorex Transplantation AB (publ)?
As of the previous close price of SEK0.91, shares in Glycorex Transplantation AB (publ) had a market capitalisation of SEK67.35m.
Where are Glycorex Transplantation AB (publ) shares listed?
Here are the trading details for Glycorex Transplantation AB (publ):
- Country of listing: Sweden
- Exchange: NGM
- Ticker Symbol: GTAB B
What kind of share is Glycorex Transplantation AB (publ)?
Based on an overall assessment of its quality, value and momentum Glycorex Transplantation AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Glycorex Transplantation AB (publ) share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Glycorex Transplantation AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Glycorex Transplantation AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -35.96%.
As of the last closing price of SEK0.91, shares in Glycorex Transplantation AB (publ) were trading -42.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Glycorex Transplantation AB (publ) PE Ratio?
The Glycorex Transplantation AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.91.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Glycorex Transplantation AB (publ)?
Glycorex Transplantation AB (publ)'s management team is headed by:
- Johan Nilsson - CEO
- Kurt Nilsson - DCE
- Kerstin Jakobsson - IND